Tilray® Expands Global Leadership Team with New COO and CFO
January 14 2020 - 8:00AM
Business Wire
Former Revlon executive, Jon Levin, joins as
Chief Operating Officer and former Molson Coors and Pharmaca
executive, Michael Kruteck joins as Chief Financial Officer
Current Tilray CFO, Mark Castaneda, to stay
on in strategic business development role
Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis
production, research, cultivation, and distribution, announces the
expansion of its global senior leadership team with two strategic
hires: Jon Levin as Chief Operating Officer, who was formerly with
Revlon, and Michael Kruteck as Chief Financial Officer, who was
formerly with Molson Coors and Pharmaca. Mr. Kruteck’s appointment
will be effective immediately after filing the Annual Report on
Form 10-K for the year ended December 31, 2019. Mark Castaneda,
Tilray’s current CFO, will take on the role of Strategic Business
Development and continue to advise the company and assist in
Kruteck’s transition.
“We are thrilled to have these experienced leaders join our team
as we continue to disrupt the global pharmaceutical, alcohol, CPG
and functional food and beverage industries,” said Brendan Kennedy,
Tilray CEO. “Jon and Michael come to Tilray with extensive
expertise in their respective fields and we look forward to their
contributions as we pioneer the future of cannabis and hemp around
the world. As CFO, Mark has led the company through its IPO and
substantial growth in the past couple years and we thank him as he
transitions to a new strategic role with the company.”
Levin, COO, joins Tilray from Revlon where he most recently was
General Manager, U.S. Mass Markets, responsible for the consumer
products sold through major retailers in the United States. With 25
years of experience, Levin has general management knowledge in
diverse industries including beauty and health, CPG and sporting
goods. Prior to Revlon, he was the Executive Vice President, Sales,
for Ferrara Candy Company, and had senior sales leadership
positions with Nautilus, Wrigley and Acosta. Levin has a B.S. in
Economics from Portland State University and a degree in Executive
Management from Cornell University.
Kruteck, CFO, served multiple senior financial roles at Molson
Coors Beverage Company and most recently as CFO for Pharmaca
Integrative Pharmacy. With over 30 years of experience, Kruteck
possesses a broad finance background with specific experience in
financial and operational transformations, supply chain, corporate
finance, and financial planning and analysis. Michael received his
MBA from the Garvin School of International Management
(Thunderbird) and his B.A. from the University of Colorado at
Boulder.
Tilray’s current CFO, Mark Castaneda, who joined the company in
March 2018, will take on the role of Strategic Business Development
focusing on strategic initiatives for Tilray while also supporting
Kruteck through the transition.
About Tilray® Tilray (NASDAQ: TLRY) is a global pioneer
in the research, cultivation, production and distribution of
cannabis and cannabinoids currently serving tens of thousands of
patients and consumers in 15 countries spanning five
continents.
Forward Looking Statements This press release contains
“forward-looking statements” within the meaning of the U.S. Private
Securities Litigation Reform Act of 1995 and “forward-looking
information” within the meaning of Canadian securities laws, or
collectively, forward-looking statements. Forward-looking
statements in this press release may be identified by the use of
words such as, “may”, “would”, “could”, “will”, “likely”, “expect”,
“anticipate”, “believe, “intend”, “plan”, “forecast”, “project”,
“estimate”, “outlook” and other similar expressions.
Forward-looking statements are not a guarantee of future
performance and are based upon a number of estimates and
assumptions of management in light of management’s experience and
perception of trends, current conditions and expected developments,
as well as other factors that management believes to be relevant
and reasonable in the circumstances, including assumptions in
respect of current and future market conditions, the current and
future regulatory environment and future approvals and permits.
Actual results, performance or achievement could differ materially
from that expressed in, or implied by, any forward-looking
statements in this press release, and, accordingly, you should not
place undue reliance on any such forward-looking statements and
they are not guarantees of future results. Please see the heading
“Risk Factors” in Tilray’s Quarterly Report on Form 10-Q, which was
filed with the Securities and Exchange Commission on November 13,
2019, for a discussion of the material risk factors that could
cause actual results to differ materially from the forward-looking
information. Tilray does not undertake to update any
forward-looking statements that are included herein, except in
accordance with applicable securities laws.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200114005249/en/
Media, Global: Chrissy Roebuck, +1-833-206-8161, news@tilray.com
Investors: Rachel Perkins, +1-646-277-1221,
rachel.perkins@icrinc.com
Tilray Brands (NASDAQ:TLRY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tilray Brands (NASDAQ:TLRY)
Historical Stock Chart
From Sep 2023 to Sep 2024